Rob Johnson, Managing Partner, attended Cancer Advance Boston 2016 on April 4-5.
Rob is a business development consultant and manages Alacrita's Boston office. He has a particular interest in oncology and provides business development support to biotech and pharma companies.
Cancer Advance Boston included networking between academics, members of industry, biotech entrepreneurs, and venture capitalists in the oncology community.